Patents by Inventor Sean Keith KELLEY

Sean Keith KELLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-CD20 OR ANTI-CD38 ANTIBODIES
    Publication number: 20220098318
    Abstract: The invention provides methods of dosing for the treatment of cancers. In particular, provided are methods for treating human patients having cancer, such as a hematologic cancer, by administering a combination of an anti-TIGIT antagonist antibody and an anti-CD20 antibody or anti-CD38 antibody.
    Type: Application
    Filed: August 25, 2021
    Publication date: March 31, 2022
    Inventors: Raymond D. MENG, Robert Wenchen HSIEH, Namrata Srivastava PATIL, Sean Keith KELLEY, Karen Lynn KLING-MILLER, William Michael FLANAGAN
  • DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-PD-L1 ANTAGONIST ANTIBODIES
    Publication number: 20200399376
    Abstract: The invention provides methods of dosing for the treatment of cancers. In particular, provided are methods for treating human patients having lung cancer, such as non-small cell lung cancer (NSCLC), by administering a combination of an anti-TIGIT antagonist antibody and an anti-PD-L1 antagonist antibody.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: Raymond D. MENG, Sean Keith KELLEY, Namrata Srivastava PATIL